(Q66545958)
Statements
A Phase 1 Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Candidate Human Cytomegalovirus Vaccine (VBI-1501) in Healthy Adults (English)
0 references
23 June 2016
0 references
15 September 2016
0 references
128
0 references
18 year
0 references
40 year
0 references